- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 515/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains four or more hetero rings
Patent holdings for IPC class C07D 515/22
Total number of patents in this class: 140
10-year publication summary
|
4
|
3
|
5
|
5
|
9
|
11
|
22
|
18
|
22
|
6
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3839 |
22 |
| Pharma Mar, S.A. | 215 |
16 |
| Zeno Management, Inc. | 17 |
8 |
| AstraZeneca AB | 3042 |
6 |
| Vertex Pharmaceuticals Incorporated | 1581 |
6 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
5 |
| The Regents of the University of Michigan | 4409 |
4 |
| Abbvie Inc. | 1808 |
4 |
| AbbVie Deutschland GmbH & Co. KG | 268 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
4 |
| Inflazome Limited | 92 |
4 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 153 |
4 |
| Ascentage Pharma Group Corp Limited | 122 |
4 |
| Polyphor AG | 101 |
3 |
| F. Hoffmann-La Roche AG | 7958 |
2 |
| Lawrence Livermore National Security, LLC | 1834 |
2 |
| Genzyme Corporation | 1205 |
2 |
| NATCO Pharma Limited | 197 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
2 |
| Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 51 |
2 |
| Other owners | 34 |